Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
Post-myocardial infarction heart failure dysregulates the bone vascular niche
Anti-inflammatory therapies could protect the bone vascular niche…
Specific diagnosis and therapy for children with heart failure
Specific diagnosis and therapy for children with heart failure
Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
Clonal hematopoiesis driven by mutations of DNMT3A …
NEWS: Awards & Grants
9.8 million euros for cardiovascular drug discovery and development
Jaya Krishnans Genome Biologics selected by EIC Accelerator…
Stefanie Dimmeler among highest cited researchers 2021
ICR director Stefanie Dimmeler belongs again to the highly cited researchers
ICR researchers received three awards at Joint Vascular Biology Meeting
Three awards at the 3rd Joint Dutch German Vascular Biology Meeting